EGFR and cancer: In addition to EGFR, ROS produced during DIP may activate several signal transduction cascades such as mitogen-activated protein kinases (MAPK), involved in proliferation and antiapoptotic signaling of many cancers, and lead to genomics instability and DNA damage, which have a pro-tumorigenic effect (112, 113).